Oral beclomethasone dipropionate as an initial treatment for stages 1-2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation

Ann Hematol. 2015 Dec;94(12):2073-5. doi: 10.1007/s00277-015-2483-z. Epub 2015 Sep 16.

Authors

Hisashi Yamamoto¹, Naoyuki Uchida^{2

3}, Yumiko Uchida⁴, Aya Nishida¹, Hikari Ota¹, Kosei Kageyama¹, Izumi Nasu⁴, Sachie Wada¹, Daisuke Kaji¹, Kazuya Ishiwata¹, Shinsuke Takagi¹, Masanori Tsuji¹, Yuki Asano-Mori¹, Naofumi Matsuno¹, Go Yamamoto¹, Kazuhiro Masuoka¹, Koji Izutsu^{1

5}, Atsushi Wake¹, Akiko Yoneyama⁶, Shigeyoshi Makino⁷, Tadaaki Ito⁴, Masahiro Hayashi⁴, Shuichi Taniguchi^{1

5}

Affiliations

¹ Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
² Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. [email protected].
³ Okinaka Memorial Institute for Medical Research, Tokyo, Japan. [email protected].
⁴ Department of Pharmacology, Toranomon Hospital, Minato-ku, Tokyo, Japan.
⁵ Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
⁶ Department of Infectious Diseases, Toranomon Hospital, Minato-ku, Tokyo, Japan.
⁷ Department of Transfusion Medicine, Toranomon Hospital, Minato-ku, Tokyo, Japan.

PMID: 26374433
DOI: 10.1007/s00277-015-2483-z

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Adult
Aged
Aged, 80 and over
Allografts
Anti-Inflammatory Agents / administration & dosage*
Beclomethasone / administration & dosage*
Cord Blood Stem Cell Transplantation*
Female
Gastrointestinal Diseases* / drug therapy
Gastrointestinal Diseases* / mortality
Graft vs Host Disease* / drug therapy
Graft vs Host Disease* / mortality
Hematologic Neoplasms* / mortality
Hematologic Neoplasms* / therapy
Humans
Male
Middle Aged

Substances

Anti-Inflammatory Agents
Beclomethasone